Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Rheumatology|December 4, 2018
Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's diseaseSho Ueda, Mitsuteru Akahoshi, Atsunobu Takeda, et al.
PNAS Nexus|May 9, 2022
Circulating inflammatory monocytes oppose microglia and contribute to cone cell death in retinitis pigmentosaJun Funatsu, Yusuke Murakami, Shotaro Shimokawa, et al.
Redox Biology|September 22, 2023
Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosisKazuhisa Yamada, Akira Tazaki, Nanako Ushio-Watanabe, et al.
Ocular Immunology and Inflammation|November 6, 2018
Association Study of ARMC9 Gene Variants with Vogt-Koyanagi-Harada Disease in Japanese PatientsTomoko Ohno, Akira Meguro, Masaki Takeuchi, et al.
Frontiers in Medicine|October 17, 2022
Factors associated with low prevalence of Fuchs' uveitis syndrome in JapanYu Yoneda, Yoshihiko Usui, Rie Tanaka, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Plos One|May 22, 2020
Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese populationTakuto Sakono, Akira Meguro, Masaki Takeuchi, et al.
Nature|March 28, 2008
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Mark E Kleinman, Kiyoshi Yamada, Atsunobu Takeda, et al.
Frontiers in Immunology|January 23, 2023
Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central toleranceMariko Shirane, Nobuyo Yawata, Daisuke Motooka, et al.
Nature Medicine|August 12, 2009
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthRomulo J C Albuquerque, Takahiko Hayashi, Won Gil Cho, et al.
Pageof 9